Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124
Reference
- Pourroy, B.; Aumente, M.D.; Koenecke, C.; Stanulla, M.; Ferreri, A.J.M.; Murciano-Carillo, T.; Dandapani, M.; Ritzmann, T.A.; Barba, P.; Chatelut, E.; et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Pourroy, B.; Aumente, M.D.; Koenecke, C.; Stanulla, M.; Ferreri, A.J.M.; Carillo, T.M.; Dandapani, M.; Ritzmann, T.A.; Barba, P.; Chatelut, E.; et al. Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124. Cancers 2026, 18, 941. https://doi.org/10.3390/cancers18060941
Pourroy B, Aumente MD, Koenecke C, Stanulla M, Ferreri AJM, Carillo TM, Dandapani M, Ritzmann TA, Barba P, Chatelut E, et al. Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124. Cancers. 2026; 18(6):941. https://doi.org/10.3390/cancers18060941
Chicago/Turabian StylePourroy, Bertrand, Maria D. Aumente, Christian Koenecke, Martin Stanulla, Andrés J. M. Ferreri, Thais M. Carillo, Madhumita Dandapani, Timothy A. Ritzmann, Pere Barba, Etienne Chatelut, and et al. 2026. "Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124" Cancers 18, no. 6: 941. https://doi.org/10.3390/cancers18060941
APA StylePourroy, B., Aumente, M. D., Koenecke, C., Stanulla, M., Ferreri, A. J. M., Carillo, T. M., Dandapani, M., Ritzmann, T. A., Barba, P., Chatelut, E., Ingley, K. M., Morris, E., Schorb, E., Liebig, S., Schwartz, S., Howard, S. C., Combs, R., Tentoni, N., Lowe, J., ... Rizzari, C. (2026). Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124. Cancers, 18(6), 941. https://doi.org/10.3390/cancers18060941

